SG10201604667YA - Pharmaceutical preparation - Google Patents
Pharmaceutical preparationInfo
- Publication number
- SG10201604667YA SG10201604667YA SG10201604667YA SG10201604667YA SG10201604667YA SG 10201604667Y A SG10201604667Y A SG 10201604667YA SG 10201604667Y A SG10201604667Y A SG 10201604667YA SG 10201604667Y A SG10201604667Y A SG 10201604667YA SG 10201604667Y A SG10201604667Y A SG 10201604667YA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical preparation
- pharmaceutical
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011086402 | 2011-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201604667YA true SG10201604667YA (en) | 2016-07-28 |
Family
ID=46969013
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013076450A SG194182A1 (en) | 2011-04-08 | 2012-03-23 | Pharmaceutical preparation |
| SG10201604667YA SG10201604667YA (en) | 2011-04-08 | 2012-03-23 | Pharmaceutical preparation |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013076450A SG194182A1 (en) | 2011-04-08 | 2012-03-23 | Pharmaceutical preparation |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20140086973A1 (en) |
| EP (1) | EP2695621B1 (en) |
| JP (1) | JP5925188B2 (en) |
| KR (1) | KR101902039B1 (en) |
| CN (1) | CN103561769B (en) |
| CA (1) | CA2832303C (en) |
| SG (2) | SG194182A1 (en) |
| WO (1) | WO2012137610A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140068849A (en) * | 2011-06-14 | 2014-06-09 | 가부시키가이샤 시세이도 | Thin film supporting hyaluronic acid or derivative thereof and thin film cosmetic |
| JP5807484B2 (en) * | 2011-09-27 | 2015-11-10 | 日立化成株式会社 | Thin film and manufacturing method thereof |
| JP2014153996A (en) * | 2013-02-12 | 2014-08-25 | Hitachi Chemical Co Ltd | Sheet, method for manufacturing sheet, contact relaxing sheet, and method for transferring rfid inlay and thin film layer to adherend |
| JP6409253B2 (en) * | 2013-07-10 | 2018-10-24 | 日立化成株式会社 | Nano thin film transfer sheet, method for producing nano thin film transfer sheet, and method for transferring nano thin film layer to adherend |
| JP6405605B2 (en) * | 2013-07-10 | 2018-10-17 | 日立化成株式会社 | Nano thin film transfer sheet and method for producing nano thin film transfer sheet |
| JP6286903B2 (en) * | 2013-07-10 | 2018-03-07 | 日立化成株式会社 | Nano thin film transfer sheet and method for producing nano thin film transfer sheet |
| JP6363833B2 (en) * | 2013-11-22 | 2018-07-25 | ナノシータ株式会社 | Thin film polymer structure |
| JP6693049B2 (en) * | 2015-05-21 | 2020-05-13 | 日立化成株式会社 | Nano thin film transfer sheet and transfer method |
| FR3044555B1 (en) * | 2015-12-07 | 2020-03-06 | Centre National De La Recherche Scientifique - Cnrs - | FILM COMPRISING AN OLIGOSACCHARIDE POLYSULFATE AND A POLYCATION AND METHOD FOR THE PRODUCTION THEREOF |
| CN105902523A (en) * | 2016-03-14 | 2016-08-31 | 苏州博创康源生物技术有限公司 | Drug-loaded tissue adhesive film and preparation method thereof |
| EP3691654A4 (en) | 2017-09-25 | 2021-11-24 | Surface Pharmaceuticals, Inc. | Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease |
| JP7287032B2 (en) | 2019-03-20 | 2023-06-06 | 株式会社リコー | SHEET, SHEET LAMINATED PRODUCT, PHARMACEUTICAL, SHEET MANUFACTURING METHOD, AND SHEET LAMINATED MANUFACTURING METHOD |
| WO2024059952A1 (en) * | 2022-09-23 | 2024-03-28 | Madd Ophthalmics Ltd. | Mucoadhesive drug delivery systems and methods of use |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5948409A (en) * | 1982-09-10 | 1984-03-19 | Teikoku Seiyaku Kk | Promotor for orthodontic tooth mobility |
| US20040111275A1 (en) * | 2002-11-15 | 2004-06-10 | Kroll David B. | Methods for marketing and generating revenue from edible thin films |
| DE10353186A1 (en) * | 2003-11-13 | 2005-06-16 | Röhm GmbH & Co. KG | Multilayer dosage form containing a modulatory substance in relation to the release of active ingredient |
| EP1720555A1 (en) * | 2004-02-26 | 2006-11-15 | Advanced Ocular Systems Limited | Tetracycline derivatives for the treatment of ocular pathologies |
| US7758892B1 (en) * | 2004-05-20 | 2010-07-20 | Boston Scientific Scimed, Inc. | Medical devices having multiple layers |
| JP4268912B2 (en) | 2004-08-26 | 2009-05-27 | 株式会社メニコン | Drug sustained-release contact lens kit |
| JPWO2006025592A1 (en) | 2004-08-31 | 2008-05-08 | 武岡 真司 | Thin film polymer structure and preparation method thereof |
| US20090088679A1 (en) * | 2005-02-07 | 2009-04-02 | Massachusetts Institute Of Technology | Electronically-Degradable Layer-by-Layer Thin Films |
| SE530184C2 (en) * | 2005-12-23 | 2008-03-18 | Kjell Stenberg | Bioadhesive pharmaceutical film composition containing low viscous alginates |
| US10035337B2 (en) * | 2006-10-27 | 2018-07-31 | Nanotheta Co, Ltd. | Thin film polymer structure having different modification on opposite sides thereof |
| CN101293924A (en) * | 2007-04-24 | 2008-10-29 | 上海国健生物技术研究院 | Monoclone antibody with combined function epiposition, specificity of osteopontin and in preparing antineoplastic diversion medicaments |
| US8815273B2 (en) * | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
| US20090258045A1 (en) * | 2008-03-18 | 2009-10-15 | Massachusetts Institute Of Technology | Structures including antimicrobial peptides |
| US9949942B2 (en) * | 2008-05-09 | 2018-04-24 | Mati Therapeutics Inc. | Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
| WO2010021973A2 (en) * | 2008-08-17 | 2010-02-25 | Massachusetts Institute Of Technology | Controlled delivery of bioactive agents from decomposable films |
-
2012
- 2012-03-23 CN CN201280017395.5A patent/CN103561769B/en active Active
- 2012-03-23 US US14/110,248 patent/US20140086973A1/en not_active Abandoned
- 2012-03-23 EP EP12768019.7A patent/EP2695621B1/en active Active
- 2012-03-23 SG SG2013076450A patent/SG194182A1/en unknown
- 2012-03-23 CA CA2832303A patent/CA2832303C/en active Active
- 2012-03-23 JP JP2013508810A patent/JP5925188B2/en active Active
- 2012-03-23 KR KR1020137029204A patent/KR101902039B1/en active IP Right Grant
- 2012-03-23 SG SG10201604667YA patent/SG10201604667YA/en unknown
- 2012-03-23 WO PCT/JP2012/057519 patent/WO2012137610A1/en active Application Filing
-
2017
- 2017-07-27 US US15/661,970 patent/US20170354615A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20140086973A1 (en) | 2014-03-27 |
| CA2832303C (en) | 2018-10-30 |
| SG194182A1 (en) | 2013-11-29 |
| WO2012137610A1 (en) | 2012-10-11 |
| CA2832303A1 (en) | 2012-10-11 |
| EP2695621A4 (en) | 2014-09-10 |
| EP2695621B1 (en) | 2020-08-12 |
| JP5925188B2 (en) | 2016-05-25 |
| JPWO2012137610A1 (en) | 2014-07-28 |
| US20170354615A1 (en) | 2017-12-14 |
| CN103561769B (en) | 2017-06-06 |
| EP2695621A1 (en) | 2014-02-12 |
| KR101902039B1 (en) | 2018-09-27 |
| CN103561769A (en) | 2014-02-05 |
| KR20140043339A (en) | 2014-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP3864A (en) | Pharmaceutical composition | |
| HRP20181896T1 (en) | Pharmaceutical formulations | |
| PL2776416T3 (en) | Pharmaceutical compounds | |
| SG10201604667YA (en) | Pharmaceutical preparation | |
| GB201118232D0 (en) | Pharmaceutical composition | |
| HK1201534A1 (en) | Pharmaceutical compounds | |
| HK1189158A1 (en) | Pharmaceutical composition | |
| GB201119799D0 (en) | Pharmaceutical compounds | |
| GB201105298D0 (en) | Pharmaceutical preparation | |
| EP2731610A4 (en) | Pharmaceutical combination | |
| GB201113163D0 (en) | Pharmaceutical compounds | |
| GB201118876D0 (en) | Pharmaceutical compounds | |
| PL2691119T3 (en) | Pharmaceutical preparation | |
| EP2727593A4 (en) | Nicorandil-containing pharmaceutical composition | |
| EP2711010A4 (en) | Pharmaceutical composition | |
| HUP1100444A2 (en) | Pharmaceutical composition | |
| HUP1100445A2 (en) | Pharmaceutical composition | |
| GB201119796D0 (en) | Pharmaceutical comopounds | |
| GB201120735D0 (en) | New pharmaceutical uses | |
| GB201111577D0 (en) | Pharmaceutical formulations | |
| GB201118875D0 (en) | Pharmaceutical compounds | |
| GB201118874D0 (en) | Pharmaceutical compounds | |
| GB201117359D0 (en) | Pharmaceutical compounds | |
| GB201105026D0 (en) | Pharmaceutical compounds | |
| PL390620A1 (en) | Pharmaceutical preparation |